Artios Pharma

Artios Pharma

Developing breakthrough cancer treatments that target DNA Damage Response (DDR) pathways to selectively kill cancer cells. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD946m—1.4b (Dealroom.co estimates Jul 2021.)
Company register number 09931309
Babraham England (HQ)
Authorizing premium user...